2023-00355. Foreign-Trade Zone (FTZ) 27-Boston, Massachusetts; Authorization of Production Activity, Wyeth Pharmaceuticals, LLC (Shingles and Flu Vaccines), Andover, Massachusetts  

  • Start Preamble

    On September 8, 2022, Wyeth Pharmaceuticals, LLC (Wyeth) submitted a notification of proposed production activity to the FTZ Board for its facility within Subzone 27R, in Andover, Massachusetts.

    The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including notice in the Federal Register inviting public comment (87 FR 56928, September 16, 2022). On January 6, 2023, the applicant was notified of the Start Printed Page 1559 FTZ Board's decision that no further review of the activity is warranted at this time. The production activity described in the notification was authorized, subject to the FTZ Act and the FTZ Board's regulations, including Section 400.14.

    Start Signature

    Dated: January 6, 2023.

    Elizabeth Whiteman,

    Acting Executive Secretary.

    End Signature End Preamble

    [FR Doc. 2023-00355 Filed 1-10-23; 8:45 am]

    BILLING CODE 3510-DS-P

Document Information

Published:
01/11/2023
Department:
Foreign-Trade Zones Board
Entry Type:
Notice
Document Number:
2023-00355
Pages:
1558-1559 (2 pages)
Docket Numbers:
B-43-2022
PDF File:
2023-00355.pdf